All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

MicroRNA signature associated with poor outcome of glioblastoma patients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F14%3A00062729" target="_blank" >RIV/65269705:_____/14:00062729 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/14:00080178

  • Result on the web

    <a href="http://neuro-oncology.oxfordjournals.org/content/16/suppl_5/v126.2" target="_blank" >http://neuro-oncology.oxfordjournals.org/content/16/suppl_5/v126.2</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1093/neuonc/nou262.6" target="_blank" >10.1093/neuonc/nou262.6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    MicroRNA signature associated with poor outcome of glioblastoma patients

  • Original language description

    BACKGROUND: It is very important to find new biomarkers which can predict clinical outcomes of glioblastoma (GBM) and help in treatment decissions. MicroRNAs (miRNAs) are small, non-coding RNAs that function as post-transcriptional regulators of gene expression and play key role in pathogenesis of wide range of cancer. Aim of our study is to identify miRNA signature associated with the more aggressive phenotype of GBMs, which will enable sensitive prediction of clinical outcome in GBM patients. METHODS:We determined the expression profile of 667 miRNAs in tumor tissues of 58 patients with primary GBM with completed concomitant chemoradiotherapy with temozolomide and 12 non-malignant brain tissues obtained from patients with drug-resistant anteromedialtemporal lobe epilepsy. Methylation status of MGMT promoter (methylation-specific HRM), isocitrate dehydrogenase (IDH1) status (immunohistochemistry) and co-deletion of 1p/19q (FISH) was also evaluated. RESULTS: We have confirmed frequen

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů